Table 1.
Study | Type | Number of cases | Presentation | Duration between development of ON and vaccination | Vaccine | Age |
---|---|---|---|---|---|---|
Alvarez et al. (pre-print) | Observational study, Cohort | 55 | 27 papillitis | Median - 18 days (range: 1-69) | 38/55- AstraZeneca 13- Pfizer-BioNTech 4 - Sinovac | Median -45 years (range: 18-75) |
Leber et al. | Case report | 1 | 14- MOG + Acute thyroiditis, Bilateral ON | CoronaVac |